Stories
Beyond relevant information about Mirati’s path to innovation for patients, our humanizing journalism showcases the work of our employees.
Beyond relevant information about Mirati’s path to innovation for patients, our humanizing journalism showcases the work of our employees.
People & Culture
Learn more about how our team shows up.
Science
Learn more about our science.
Citizenship
Read more about how our impact goes beyond discovering, developing, and delivering medicines.

Mirati shows continued commitment to local San Diego communities with first-ever Month of Service 2022
Read more

Mirati remains committed to raise funds for cancer research at Padres Pedal the Cause 2022
Read more

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021
Read more
Perspectives
Read about our take on trending topics that impact our work and patients.
People & Culture
Learn more about how our team shows up.

Stepping outside your professional comfort zone
Read more

Effective leadership styles for leaders in STEM fields
Read more

The power of self advocacy
Read more

Operating with a growth mindset
Read more

A culture designed to unleash the potential of our people
Read more

Bridging R&D and the real world
Read more

I’m in the race of a lifetime
Read more

I wanted to do more to help patients fight cancer
Read more
Science
Learn more about our science.

KRAS Conversations: A starting point for treating KRAS-mutant cancers
Read more

KRAS Conversations: The challenge of targeting KRAS
Read more

What sets KRAS biomarkers apart from other more common biomarkers?
Read more

KRAS Conversations: Looking toward the future of pan-KRAS therapies
Read more

KRAS Conversations: The promise of biomarker testing
Read more

In exploration of the next generation of precision oncology
Read more

KRAS Conversations: Providing patients with options
Read more

Every drug discovery scientist is an inventor
Read more
KRASG12C proteins don’t quit
Read more
Citizenship
Read more about how our impact goes beyond discovering, developing, and delivering medicines.

Mirati shows continued commitment to local San Diego communities with first-ever Month of Service 2022
Read more

Mirati remains committed to raise funds for cancer research at Padres Pedal the Cause 2022
Read more

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021
Read more
Perspectives
Read about our take on trending topics that impact our work and patients.

The importance and impact of accessible clinical research studies
Read more

World Lung Cancer Day
Read more

The power in controlling your career progression narrative
Read more

Advancing diversity, equity, and inclusion efforts in clinical trials
Read more

Improving diversity in clinical trials
Read more

The importance of health literacy in health equity
Read more

Staying aligned to your motivators while being unapologetically confident
Read more

Innovation with a purpose — Early discovery employee spotlight
Read more

Colorectal Cancer Awareness Month – Hope on the Horizon
Read more

5 ways to bridge the health equity gap for cancer patients
Read more

Creating a successful commercial organization: Delivering against our promise to help people living with cancer
Read more

Addressing unmet medical needs through a breadth of targeted therapeutics
Read more

How innovation has the potential to change patients’ lives
Read more

Building a global medical team from the ground up
Read more

ASCO 2022: There is still more to do
Read more

Why I’m optimistic about the future of targeted oncology
Read more

KRAS Conversations: Looking toward the future of pan-KRAS therapies
Read more

KRAS Conversations: The promise of biomarker testing
Read more

Learn more about KRAS mutations
Read more

Exploiting cancer’s weakness, precisely
Read more

KRAS Conversations: Providing patients with options
Read more

The changing landscape of targeting cancer mutations
Read more
Topic: Advocacy

Colorectal Cancer Awareness Month – Hope on the Horizon
Read more

5 ways to bridge the health equity gap for cancer patients
Read more

Mirati remains committed to raise funds for cancer research at Padres Pedal the Cause 2022
Read more

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021
Read more

I wanted to do more to help patients fight cancer
Read more
Topic: Careers

Staying aligned to your motivators while being unapologetically confident
Read more

Stepping outside your professional comfort zone
Read more

Mirati remains committed to raise funds for cancer research at Padres Pedal the Cause 2022
Read more

The power of self advocacy
Read more

Operating with a growth mindset
Read more

A culture designed to unleash the potential of our people
Read more

Bridging R&D and the real world
Read more

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021
Read more
Topic: Collaboration

Creating a successful commercial organization: Delivering against our promise to help people living with cancer
Read more

How innovation has the potential to change patients’ lives
Read more

Why I’m optimistic about the future of targeted oncology
Read more

In exploration of the next generation of precision oncology
Read more

Learn more about KRAS mutations
Read more
Topic: Culture

The importance of health literacy in health equity
Read more

Innovation with a purpose — Early discovery employee spotlight
Read more

Creating a successful commercial organization: Delivering against our promise to help people living with cancer
Read more

How innovation has the potential to change patients’ lives
Read more

Mirati remains committed to raise funds for cancer research at Padres Pedal the Cause 2022
Read more

The power of self advocacy
Read more

Why I’m optimistic about the future of targeted oncology
Read more

Operating with a growth mindset
Read more

A culture designed to unleash the potential of our people
Read more

Bridging R&D and the real world
Read more

Mirati participates as the largest corporate team in Padres Pedal the Cause 2021
Read more
Topic: KRAS

Addressing unmet medical needs through a breadth of targeted therapeutics
Read more

ASCO 2022: There is still more to do
Read more

KRAS Conversations: A starting point for treating KRAS-mutant cancers
Read more

KRAS Conversations: The challenge of targeting KRAS
Read more

What sets KRAS biomarkers apart from other more common biomarkers?
Read more

KRAS Conversations: Looking toward the future of pan-KRAS therapies
Read more

KRAS Conversations: The promise of biomarker testing
Read more

In exploration of the next generation of precision oncology
Read more

Learn more about KRAS mutations
Read more

Exploiting cancer’s weakness, precisely
Read more

KRAS Conversations: Providing patients with options
Read more

The changing landscape of targeting cancer mutations
Read more
KRASG12C proteins don’t quit
Read more
Topic: R&D

Addressing unmet medical needs through a breadth of targeted therapeutics
Read more

How innovation has the potential to change patients’ lives
Read more

ASCO 2022: There is still more to do
Read more

In exploration of the next generation of precision oncology
Read more

Exploiting cancer’s weakness, precisely
Read more

A culture designed to unleash the potential of our people
Read more

Bridging R&D and the real world
Read more

Every drug discovery scientist is an inventor
Read more

The changing landscape of targeting cancer mutations
Read more